Research Article
Immunological Alterations due to Hemodialysis Might Interfere with Early Complications in Renal Transplantation
Table 4
TGFβ level, sCD30 level, and complement activation before, during, and after hemodialysis.
| | Before dialysis | After one hour of dialysis | At the end of dialysis | 15 minutes after end of dialysis | Reference range |
| | TGFβ (ng/ml) | | Median (min–max) | 23.71 (14.4-44.34) | 13.47 (6.38-22.92) | 20.58 (16.19-23.25) | 20.68 (13.24-27.89) | 18.3-63.4 | | sCD30 (ng/ml) | | Median (min–max) | 80.1 (45.05-205.88) | 84.45 (38.18-212.96) | 88.67 (41.75-212.47) | 85.96 (55.2-232.18) | 7.7-60.5 | | Classical pathway (%) | | Median (min–max) | 106.4 (86.7-124.8) | 101.7 (80.6-115) | 104.4 (80.8-114.6) | 103.9 (85.5-118.5) | 69-129 | | Alternative pathway (%) | | Median (min–max) | 86.7 (54.4-115) | 84.5 (49.8-98.4) | 78.2 (41.8-94.8) | 87.9 (63.9-104.8) | 30-113 |
|
|
Mentioned in the manufacturer’s instructions (Human TGF- β1 Quantikine ELISA, R&D Systems; Human sCD30 ELISA, BioVendor; Wieslab COMPL CP310, Euro-Diagnostica; Wieslab COMPL AP 330, Euro-Diagnostica). min: minimum; max: maximum. Statistical analysis with nonparametric tests are shown in Table 3. |
